Honokiol: A potent chemotherapy candidate for human colorectal carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 23

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

380

HTML

3551

Figures (1-8)

169

Tables (1-3)

109

Sum=4209

Dec 1, 2004 (publication date) through Apr 28, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Colorectal Cancer

World J Gastroenterol. Dec 1, 2004; 10(23): 3459-3463
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3459

Full Size Figure Download Figure

Figure 4 Apoptosis of RKO cells detected by FCM. (A) control; (B) 5 μg/mL; (C) 10 μg/mL; (D) 15 μg/mL.

Citation: Chen F, Wang T, Wu YF, Gu Y, Xu XL, Zheng S, Hu X. Honokiol: A potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol 2004; 10(23): 3459-3463
URL: https://www.wjgnet.com/1007-9327/full/v10/i23/3459.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i23.3459